Movement Alert｜Genscript Biotech Rises 5.27% in Regular Trading, CXO Sector Mid-Year Earnings Window Continues to Catalyze

Market Focus07-13

On July 13, Genscript Biotech rose 5.27% in regular trading, trading at HK$14.66/share, with turnover of approximately HK$81.69 million.

On the news front, the CXO sector's mid-year earnings realization window has opened, with multiple brokerages highlighting a significant acceleration in new order signings across the industry. After the gradual digestion of earlier low-price orders, the sector's revenue and profit dual inflection point has been confirmed. Data shows that 22 listed CXO companies reported Q1 revenue and net profit growth of 18.6% and 21.9% year-over-year respectively, with domestic CXO firms seeing robust orders and both volume and pricing improvements, as financial statement improvements are being progressively realized.

Genscript Biotech is an investment holding company primarily engaged in life sciences research products and services, with businesses spanning gene synthesis, biologics development, industrial synthetic biology, and cell therapy. Its associate Legend Biotech's CARVYKTI generated approximately US$597 million in net trade sales in Q1, up 62% year-over-year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1110705452?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-13 09:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110705452","market":"us","top_or_hot":-1,"title":"Movement Alert｜Genscript Biotech Rises 5.27% in Regular Trading, CXO Sector Mid-Year Earnings Window Continues to Catalyze","media":"Market Focus","content":"<p><p>On July 13, Genscript Biotech rose 5.27% in regular trading, trading at HK$14.66/share, with turnover of approximately HK$81.69 million.</p><p>On the news front, the CXO sector's mid-year earnings realization window has opened, with multiple brokerages highlighting a significant acceleration in new order signings across the industry. After the gradual digestion of earlier low-price orders, the sector's revenue and profit dual inflection point has been confirmed. Data shows that 22 listed CXO companies reported Q1 revenue and net profit growth of 18.6% and 21.9% year-over-year respectively, with domestic CXO firms seeing robust orders and both volume and pricing improvements, as financial statement improvements are being progressively realized.</p><p>Genscript Biotech is an investment holding company primarily engaged in life sciences research products and services, with businesses spanning gene synthesis, biologics development, industrial synthetic biology, and cell therapy. Its associate Legend Biotech's CARVYKTI generated approximately US$597 million in net trade sales in Q1, up 62% year-over-year.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Genscript Biotech Rises 5.27% in Regular Trading, CXO Sector Mid-Year Earnings Window Continues to Catalyze</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Genscript Biotech Rises 5.27% in Regular Trading, CXO Sector Mid-Year Earnings Window Continues to Catalyze\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-13 09:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 13, Genscript Biotech rose 5.27% in regular trading, trading at HK$14.66/share, with turnover of approximately HK$81.69 million.</p><p>On the news front, the CXO sector's mid-year earnings realization window has opened, with multiple brokerages highlighting a significant acceleration in new order signings across the industry. After the gradual digestion of earlier low-price orders, the sector's revenue and profit dual inflection point has been confirmed. Data shows that 22 listed CXO companies reported Q1 revenue and net profit growth of 18.6% and 21.9% year-over-year respectively, with domestic CXO firms seeing robust orders and both volume and pricing improvements, as financial statement improvements are being progressively realized.</p><p>Genscript Biotech is an investment holding company primarily engaged in life sciences research products and services, with businesses spanning gene synthesis, biologics development, industrial synthetic biology, and cell therapy. Its associate Legend Biotech's CARVYKTI generated approximately US$597 million in net trade sales in Q1, up 62% year-over-year.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1110705452","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110705452","pubTimestamp":1783906790,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 13, Genscript Biotech rose 5.27% in regular trading, trading at HK$14.66/share, with turnover of approximately HK$81.69 million.On the news front, the CXO sector's mid-year earnings...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"走势提醒|金斯瑞生物常规交易上涨5.27%，CXO板块年中盈利窗口持续催化","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"On July 13, Genscript Biotech rose 5.27% in regular trading, trading at HK$14.66/share, with turnover of approximately HK$81.69 million.On the news front, the CXO sector's mid-year earnings realization window has opened, with multiple brokerages highlighting a significant acceleration in new order signings across the industry. After the gradual digestion of earlier low-price orders, the sector's revenue and profit dual inflection point has been confirmed. Data shows that 22 listed CXO companies reported Q1 revenue and net profit growth of 18.6% and 21.9% year-over-year respectively, with domestic CXO firms seeing robust orders and both volume and pricing improvements, as financial statement improvements are being progressively realized.Genscript Biotech is an investment holding company primarily engaged in life sciences research products and services, with businesses spanning gene synthesis, biologics development, industrial synthetic biology, and cell therapy. Its associate Legend Biotech's CARVYKTI generated approximately US$597 million in net trade sales in Q1, up 62% year-over-year.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1110705452","isCrawlerRequest":true}